| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |